Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus.
The case of a 40 year old female patient of SLE who developed fatal neuroleptic malignant syndrome following administration of serenase (haloperidol) is reported. Relevant literature has been reviewed.
Division of Medicine and Rheumatology, PD Hinduja Hospital and Medical Research Centre, Mumbai.
A
A
Sule
S
S
Gohar
G
G
Mittal
C
C
Balakrishnan
G
G
Mangat
V R
VR
Joshi
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*
D018726:Anti-Dyskinesia Agents; D006220:Haloperidol